Manni Mohyuddin's guest appearances

Manni Mohyuddin

Oncology Data Advisor

Plenary Session

Rahul Banerjee

Mark Lewis

John McConnell

Carl Hart

Marty Makary

Adam Cifu

Vinay Prasad

Jenny Gill

Tom DeLoughery

Dan Morgan

John Ioannidis

David Carr

Ameet Sarpatwari

Matthew Smith

Brian Chan

OwlTail

This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit oncdata.com and conveymed.io, and don’t forget to follow us on social media for news, exclusive interviews, and more!

This playlist features episodes that were recorded live at the 2022 American Society of Hematology (ASH) Annual Meeting in New Orleans by Oncology Data Advisor and ConveyMED. For more information, visit <a href="http://oncdata.com" rel="nofollow" target="_blank">oncdata.com</a> and <a href="http://conveymed.io" rel="nofollow" target="_blank">conveymed.io</a>, and don’t forget to follow us on social media for news, exclusive interviews, and more!

Multiple Myeloma Trials and Quality News Reporting With Manni Mohyuddin, MBBS

Saroj Niraula

We have two oncology conversations for you today. The first is with Dr. Saroj Niraula of the University of Manitoba, and together we discuss the necessity of randomized controlled trials for granting FDA approval of cancer drugs. The second is with Dr. Ghulam Rehman "Manni" Mohyuddin of the University of Utah on a variety of myeloma studies, including LIGHTHOUSE, OCEANS, and HORIZON.Feasibility of RCTs: doi.org/10.1093/jncics/pkab061RR of Alternative Treatments: doi.org/10.1002/ijc.33231Study Time Reduction: doi.org/10.1001/jamainternmed.2018.8351Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

We have two oncology conversations for you today. The first is with Dr. Saroj Niraula of the University of Manitoba, and together we discuss the necessity of randomized controlled trials for granting FDA approval of cancer drugs. The second is with Dr. Ghulam Rehman "Manni" Mohyuddin of the University of Utah on a variety of myeloma studies, including LIGHTHOUSE, OCEANS, and HORIZON. Feasibility of RCTs: <a href="http://doi.org/10.1093/jncics/pkab061" rel="nofollow" target="_blank">doi.org/10.1093/jncics/pkab061</a> RR of Alternative Treatments: <a href="http://doi.org/10.1002/ijc.33231" rel="nofollow" target="_blank">doi.org/10.1002/ijc.33231</a> Study Time Reduction: <a href="http://doi.org/10.1001/jamainternmed.2018.8351" rel="nofollow" target="_blank">doi.org/10.1001/jamainternmed.2018.8351</a> Back us on Patreon! <a href="http://www.patreon.com/plenarysession" rel="nofollow" target="_blank">www.patreon.com/plenarysession</a> Check out our YouTube channel: <a href="http://www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew" rel="nofollow" target="_blank">www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew</a>

4.17 RCTs for Cancer Drug Approval with Dr. Saroj Niraula & Myeloma Studies with Dr. Manni Mohyuddin